Edible Vaccine Market Report 2026

Edible Vaccine Market Overview

• Edible Vaccine market size has reached to $9.51 billion in 2025 • Expected to grow to $14.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Rising Infectious Disease Rates Drive Growth In The Edible Vaccine Market • Market Trend: Innovative Oral Cholera Vaccines Drive Advances In The Edible Vaccine Market • North America was the largest region in 2025.

What Is Covered Under Edible Vaccine Market?

An edible vaccine is a type of vaccine produced in genetically modified plants or animals, where the vaccine is delivered through consumption rather than by injection. These vaccines stimulate an immune response in the body when an edible plant or food, such as a fruit or vegetable, is eaten. The concept aims to offer a cost-effective and easily accessible alternative to traditional vaccines, especially in developing countries. The main types of edible vaccines are inactivated vaccines, subunit vaccines, deoxyribonucleic acid (DNA) vaccines, live attenuated vaccines, and others. Inactivated vaccines refer to vaccines made from viruses or bacteria that have been killed or inactivated so they cannot cause disease but still stimulate an immune response, such as the polio and hepatitis A vaccines. The distribution channel includes hospitals, veterinary clinics, retail pharmacies, and online pharmacies, and the applications are medical care, livestock, aquaculture, agriculture, and others. It is used by various end users, such as adults, pediatrics, and animals.

What Is The Edible Vaccine Market Growth Forecast?

The edible vaccine market size is expected to see strong growth in the next few years. It will grow to $14.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to increasing demand for needle-free vaccination solutions, rising investments in edible vaccine clinical trials, expansion of livestock immunization programs, growing focus on global vaccine accessibility, advancements in regulatory approval pathways. Major trends in the forecast period include advancements in plant-based vaccine expression systems, growing focus on oral vaccine delivery methods, expansion of low-cost vaccine production models, increasing research on heat-stable vaccines, rising collaboration between biotech and agricultural sectors.

Global Edible Vaccine Market Segmentation

1) By Vaccine Type: Subunit Vaccines, Virus-Like Particle VLP Vaccines, Plant-Expressed Antigen Vaccines, Recombinant Protein Vaccines, Other Edible Vaccine Types 2) By Source: Fruits, Vegetables, Cereal Grains, Legumes, Other Edible Plants 3) By Route of Administration: Oral Fresh Plant Consumption, Oral Processed Edible Form Feed, Sublingual And Buccal Edible Extract-Based 4) By Distribution Model: Public Health And Immunization Programs, Veterinary And Animal Health Programs, Direct Farm-Level Administration, Research And Academic Institutions 5) By Application: Human Immunization, Veterinary Vaccines, Livestock, Poultry, Aquaculture Vaccines, Other Applications 6) By End User: Adults, Pediatrics, Animals Subsegments: 1) By Subunit Vaccines: Protein Subunit Vaccines, Polysaccharide Subunit Vaccines, Conjugated Subunit Vaccines 2) By Virus-Like Particle (VLP) Vaccines: Plant-Derived VLP Vaccines, Chimeric VLP Vaccines, Multi-Antigen VLP Vaccines 3) By Plant-Expressed Antigen Vaccines: Fruit-Based Edible Vaccines, Vegetable-Based Edible Vaccines, Grain-Based Edible Vaccines, Legume-Based Edible Vaccines 4) By Recombinant Protein Vaccines: Recombinant Bacterial Antigen Vaccines, Recombinant Viral Antigen Vaccines, Recombinant Parasitic Antigen Vaccines 5) By Other Edible Vaccine Types: Oral Mucosal Immunity-Targeted Vaccines, Multi-Epitope Edible Vaccines, Combination Edible Vaccines

What Are The Drivers Of The Edible Vaccine Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the edible vaccine market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that invade the body and multiply. The increasing prevalence of infectious diseases is mainly due to factors such as globalization, climate change, urbanization, and antibiotic resistance, which facilitate the spread and emergence of new pathogens. Edible vaccines are used in infectious diseases to stimulate immune responses by consuming genetically modified foods that produce antigens, offering a cost-effective and needle-free method of immunization. For instance, in March 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, the number of tuberculosis cases rose from 8, 320 in 2022 to 9, 615 in 2023, representing an increase of 1, 295 cases. Additionally, the rate per 100, 000 people went up from 2.5 in 2022 to 2.9 in 2023. Therefore, the increasing prevalence of infectious diseases is driving the growth of the edible vaccine industry. The rising research and development funding is expected to propel the growth of the edible vaccine market going forward. Research and development funding refers to financial resources allocated to systematic investigation and experimental work aimed at discovering new knowledge and developing innovative products or technologies. Government investment in research and development has been increasing as nations recognize the critical role of scientific innovation in addressing global health challenges and maintaining competitive advantage in biotechnology sectors. Rising research funding directly enables scientists and pharmaceutical companies to conduct advanced studies on edible vaccine development, clinical trials, and scaling production technologies. For instance, in December 2024, according to the Office for National Statistics, a UK-based government agency, in 2023, UK businesses spent $64.73 billion (£50.0 billion) on research and development (R&D), marking a $1.83 billion (£1.4 billion) a 2.9% increase from 2022. Therefore, rising research and development funding is driving the growth of the edible vaccine industry.

Key Players In The Global Edible Vaccine Market

Major companies operating in the edible vaccine market are Medicago Inc., Vaxart Inc., Vaxiion Therapeutics Inc., Mymetics Corporation, Profectus BioSciences Inc., GreenLight Biosciences Inc., Akston Biosciences Corporation, Icon Genetics GmbH, iBio Inc., Kentucky BioProcessing Inc., Fraunhofer USA Center for Molecular Biotechnology, Nomad Bioscience GmbH, Baiya Phytopharm Company Limited, Dow AgroSciences LLC, GenCure Biomanufacturing, Transgene SA, PlantForm Corporation, BioBetter Ltd., Moolec Science SA, Agrenvec SL

Global Edible Vaccine Market Trends and Insights

Major companies operating in the edible vaccine market are focusing on developing innovative solutions, such as oral cholera vaccine (OCV), to combat the global cholera crisis. Oral cholera vaccine (OCV) is a type of vaccine administered by mouth to prevent cholera, a severe diarrheal disease caused by the bacterium Vibrio cholerae. For instance, in August 2024, Bharat Biotech International Limited, an India-based biotechnology company, launched the Hillchol, an oral cholera vaccine (OCV) with several notable features. This live-attenuated vaccine stimulates both systemic and mucosal immune responses, protecting against cholera. Hillchol stands out for its ease of administration and does not require cold storage, making it ideal for use in resource-limited settings. Moreover, it offers long-lasting immunity with just a single dose.

Regional Outlook

North America was the largest region in the edible vaccine market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Edible Vaccine Market?

The edible vaccine market consists of sales of plant-based edible vaccines, animal-based edible vaccines, algae-based edible vaccines, and yeast-based edible vaccines. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Edible Vaccine Market Report 2026?

The edible vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including Market Report 2026?global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the edible vaccine Market Report 2026? The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the Market Report 2026?